From: Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh
Antimicrobial agents | Disk diffusion test | MIC (µg/ml) | |||||
---|---|---|---|---|---|---|---|
Disk content (µg) | Zone diameter (mm) | ||||||
R | I | S | S | I | R | ||
Ceftazidimea, b | 30 | ≤14 | 15–16 | ≥18 | ≤8 | 16 | ≥32 |
Imipenema, b | 10 | ≤15 | 16–18 | ≥19 | ≤4 | 8 | ≥16 |
Amox–Clava,d | 20/10 | ≤13 | 14–17 | ≥18 | ≤8/4 | 16/8 | ≥32/16 |
Pip–Tazob, c | 100/10 | ≤14 | 15–20 | ≥21 | ≤16/4 | 32/4–64/4 | ≥128/4 |
TMP–SMXa, d | 1.25/23.75 | ≤10 | 11–15 | ≥16 | ≤2/38 | – | ≥4/76 |
Tetracyclinea, d | 30 | ≤11 | 12–14 | ≥15 | ≤4 | 8 | ≥16 |
Amikacinb, c | 30 | ≤14 | 15–16 | ≥17 | ≤16 | 32 | ≥64 |
Gentamicinb, c | 10 | ≤12 | 13–14 | ≥15 | ≤4 | 8 | ≥16 |